XKEN
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

XKEN Trademark

Serial Number: 79355008 • Registration: 7691093

XKEN is a trademark filed by Mosaiques Diagnostics and Therapeutics AG on July 1, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Mosaiques Diagnostics and Therapeutics AG (5 trademarks)

Rotenburger Straße 20

Entity Type: 99

Trademark Details

Filing Date

July 1, 2022

Registration Date

February 18, 2025

Published for Opposition

December 31, 2024

Goods & Services

Biochemical preparations for scientific purposes; diagnostic preparations for clinical use; diagnostic reagents and preparations, except for medical or veterinary use; diagnostic reagents sold as a set, except for medical or veterinary use; chemical diagnostic reagents, except for medical or veterinary use; diagnostic reagents for in vitro applications, except for medical or veterinary use; diagnostic preparations, other than for medical or veterinary purposes; diagnostic preparations for scientific purposes; chemical preparations for scientific and biological uses, other than for medical or veterinary use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, except for medical or veterinary use

Medical services; healthcare; medical testing for diagnostic or treatment purposes; medical diagnosis of cardiovascular diseases, inflammatory diseases, and in the fields of nephrology, oncology, and transplantation; medical analysis for the diagnosis and treatment of persons; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing for diagnostic or treatment purposes

Chemical diagnostic reagents for medical purposes; diagnostic agents for medical purposes; diagnostic agents for veterinary purposes; reagents for clinical medical diagnostics; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; in vitro diagnostic preparations for medical purposes; medical and veterinary diagnostic reagents for testing of body fluids; chemical reagents for medical or veterinary purposes; biochemical preparations for use in the treatment of cardiovascular diseases and inflammatory diseases and in the fields of nephrology, oncology, and transplantation; biological diagnostic reagents for medical purposes

Medical and pharmaceutical research services; scientific and technological services, namely, scientific research, analysis, and testing in the field of clinical diagnosis; biomedical research; clinical research in the fields of cardiovascular diseases, inflammatory diseases, nephrology, oncology, and transplantation; medical laboratory services; research and development services in the field of diagnostic agents; product design and development in the field of medical technology; consulting related to pharmacology; conducting biotechnological tests, namely, testing, analysis, and evaluation of urine for scientific research purposes; computer software development in the field of data processing for medical, pharmaceutical and biotechnological applications; natural science services, namely, research services in the field of the general health of humans

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 19, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 31, 2025 FICS
FINAL DISPOSITION PROCESSED
Aug 31, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 18, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 22, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 21, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 21, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 21, 2024 ERFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 4, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 4, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 4, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 4, 2024 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 29, 2024 GNFN
FINAL REFUSAL E-MAILED
Apr 29, 2024 GNFR
FINAL REFUSAL WRITTEN
Apr 29, 2024 CNFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 29, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 10, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 10, 2024 OPNR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 1, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 1, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 1, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 1, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 1, 2024 COAR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 6, 2023 TROA
REFUSAL PROCESSED BY IB
Jun 26, 2023 RFNT
NEW REPRESENTATIVE AT IB RECEIVED
Jun 9, 2023 NREP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 8, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jun 8, 2023 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 28, 2023 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 22, 2023 RFCR
NON-FINAL ACTION WRITTEN
Apr 21, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 18, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 18, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 14, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 10, 2022 REPR